Puretech Health Plc Stock Cash And Equivalents
| PTCHFDelisted Stock | USD 3.13 0.00 0.00% |
PureTech Health plc fundamentals help investors to digest information that contributes to PureTech Health's financial success or failures. It also enables traders to predict the movement of PureTech Pink Sheet. The fundamental analysis module provides a way to measure PureTech Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PureTech Health pink sheet.
PureTech |
PureTech Health plc Company Cash And Equivalents Analysis
PureTech Health's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current PureTech Health Cash And Equivalents | 368.03 M |
Most of PureTech Health's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PureTech Health plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, PureTech Health plc has 368.03 M in Cash And Equivalents. This is 55.17% lower than that of the Healthcare sector and 17.69% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 86.38% higher than that of the company.
PureTech Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PureTech Health's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PureTech Health could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics of similar companies.PureTech Health is currently under evaluation in cash and equivalents category among its peers.
PureTech Fundamentals
| Return On Equity | -0.0152 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (9.87) % | ||||
| Current Valuation | 654.5 M | ||||
| Shares Outstanding | 278.81 M | ||||
| Shares Owned By Insiders | 15.48 % | ||||
| Shares Owned By Institutions | 72.20 % | ||||
| Price To Earning | 158.00 X | ||||
| Price To Book | 1.61 X | ||||
| Price To Sales | 51.23 X | ||||
| Revenue | 9.98 M | ||||
| Gross Profit | 17.39 M | ||||
| EBITDA | (46.95 M) | ||||
| Net Income | (60.56 M) | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 1.28 X | ||||
| Total Debt | 14.26 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | 2.03 X | ||||
| Cash Flow From Operations | (158.27 M) | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 95 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 901.7 M | ||||
| Total Asset | 946.01 M | ||||
| Z Score | 37.8 | ||||
| Net Asset | 946.01 M |
About PureTech Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PureTech Health plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PureTech Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PureTech Health plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in PureTech Pink Sheet
If you are still planning to invest in PureTech Health plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PureTech Health's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |